To further investigate the role of AMPK in AR mutation-driven hepatocarcinogenesis, we suppressed the expression of PYGB and SREBP1, two key downstream targets of AR mutations, using siRNA in hepatoma cells. This evidence concerns the gene PYGB and hepatocellular carcinoma.